J. R. “Pitt” Hyde and the development of GTx

Posted on September 21, 2011 by Sitemaster

There was a long story on Bloomberg.com yesterday about J. R. “Pitt” Hyde and why he decided to invest much of his considerable fortune in the start-up company GTx, Inc.

The story starts with Mr. Hyde’s diagnosis with prostate cancer in his early 50s — 15 years ago — and his subsequent decision to work with his urologist, Mitch Steiner, to start a new pharmaceutical company focused on the development of drugs for the treatment of prostate cancer and elated clinical conditions.

Filed under: Drugs in development | Tagged: |

« »

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives

%d bloggers like this: